These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6431267)

  • 1. Antisera against catecholamines: specificity studies and physicochemical data for anti-dopamine and anti-p-tyramine antibodies.
    Geffard M; Seguela P; Heinrich-Rock AM
    Mol Immunol; 1984 Jun; 21(6):515-22. PubMed ID: 6431267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific antisera against the catecholamines: L-3,4-dihydroxyphenylalanine, dopamine, noradrenaline, and octopamine tested by an enzyme-linked immunosorbent assay.
    Mons N; Geffard M
    J Neurochem; 1987 Jun; 48(6):1826-33. PubMed ID: 3106574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to catecholamines.
    Grota LJ; Brown GM
    Endocrinology; 1976 Mar; 98(3):615-22. PubMed ID: 1261491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to dopamine: radioimmunological study of specificity in relation to immunocytochemistry.
    Geffard M; Kah O; Onteniente B; Seguela P; Le Moal M; Delaage M
    J Neurochem; 1984 Jun; 42(6):1593-9. PubMed ID: 6427408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of antibodies to catecholamines and metabolites--syntheses of various immunogens and characterization of the resulting antibodies.
    Diener U; Knoll E; Wisser H
    Clin Chim Acta; 1981 Jan; 109(1):1-11. PubMed ID: 7471484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to histamine. Specificity studies and radioimmunological assay.
    Maneta-Peyret L; Moreau P; Dulluc J; Geffard M
    J Immunol Methods; 1986 Jun; 90(1):39-45. PubMed ID: 2423615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and characterization of anti-clonidine antibodies not cross-reacting with catecholamines.
    Dontenwill M; Bricca G; Molines A; Bousquet P; Belcourt A
    Eur J Pharmacol; 1988 May; 149(3):249-55. PubMed ID: 3409953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualization of L-dihydroxyphenylalanine in rat brain by using specific antibodies.
    Mons N; Danel N; Geffard M
    Brain Res; 1988 Jun; 451(1-2):403-7. PubMed ID: 3150819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of specific antibody against L-dopa and its ultrastructural localization of immunoreactivity in the house-shrew (Suncus murinus) lateral habenular nucleus.
    Karasawa N; Isomura G; Nagatsu I
    Neurosci Lett; 1992 Aug; 143(1-2):267-70. PubMed ID: 1359476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific detection of noradrenaline in the rat brain by using antibodies.
    Geffard M; Patel S; Dulluc J; Rock AM
    Brain Res; 1986 Jan; 363(2):395-400. PubMed ID: 3510692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new specific antibody reveals octopamine-like immunoreactivity in cockroach ventral nerve cord.
    Eckert M; Rapus J; Nürnberger A; Penzlin H
    J Comp Neurol; 1992 Aug; 322(1):1-15. PubMed ID: 1430305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.
    Boundy VA; Luedtke RR; Artymyshyn RP; Filtz TM; Molinoff PB
    Mol Pharmacol; 1993 May; 43(5):666-76. PubMed ID: 8502224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of plasma and tissue levels of tyramine by radioimmunoassay.
    Faraj BA; Mu JY; Lewis MS; Wilson JP; Israili ZH; Dayton PG
    Proc Soc Exp Biol Med; 1975 Jul; 149(3):664-9. PubMed ID: 1170571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of molindone and fluphenazine on the brain concentration of some phenolic and catecholic amines in the mouse and the rat.
    Juorio AV
    Br J Pharmacol; 1980 Nov; 70(3):475-80. PubMed ID: 6777007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of precursors of noradrenalin on the response to tyramine and sympathetic stimulation.
    BURN JH; RAND MJ
    Br J Pharmacol Chemother; 1960 Mar; 15(1):47-55. PubMed ID: 13806188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of antisera and monoclonal antibodies to serotonergic and dopaminergic ligands.
    Flurkey K; Bolger MB; Linthicum DS
    J Neuroimmunol; 1985 May; 8(2-3):115-27. PubMed ID: 3873472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma concentrations of some acidic and alcoholic metabolites derived from m- and p-tyramine, octopamine and catecholamines in humans.
    Karoum F; Moyer-Schwing J; Potkin SG; Wyatt RJ
    Commun Psychopharmacol; 1977; 1(4):343-52. PubMed ID: 354855
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of aging on p- and m-octopamine, catecholamines, and their metabolizing enzymes in the rat.
    David JC; Coulon JF; Cavoy A; Delacour J
    J Neurochem; 1989 Jul; 53(1):149-54. PubMed ID: 2566654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of amphetamine derivatives on brain dopamine and noradrenaline.
    Breese GR; Kopin IJ; Weise VK
    Br J Pharmacol; 1970 May; 38(3):537-45. PubMed ID: 4909707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of specific antibodies to catecholamines and L-3,4-dihydroxyphenylalanine. I. Preparation of the conjugates.
    Miwa A; Yoshioka M; Shirahata A; Tamura Z
    Chem Pharm Bull (Tokyo); 1977 Aug; 25(8):1904-10. PubMed ID: 562723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.